ECRI Institute PSO convenes health IT safety collaborative

The ECRI Institute Patient Safety Organization (PSO) has launched The Partnership for Promoting Health IT Patient Safety, a multi-stakeholder group that seeks to generate new knowledge on safe health IT practices.

As a collaboration between health IT vendors, providers, professional societies, PSOs, policymakers and others, the partnership aims to create a national framework to identify and address health IT safety issues within a non-punitive learning environment.

Collaborating organizations include:

  • Association for the Advancement of Medical Instrumentation
  • American College of Physician Executives
  • American Health Information Management Association
  • Association of Medical Directors of Information Systems
  • American Medical Information Association
  • California Hospital PSO
  • Healthcare Information and Management Systems Society
  • Institute for Safer Medication Practices
  • Kentucky Institute for Patient Safety and Quality
  • Michigan Hospital Association PSO
  • Midwest Alliance for Patient Safety
  • National Patient Safety Foundation
  • Ohio Patient Safety Institute
  • PSO of Florida
  • Tennessee Center for Patient Safety
  • Virginia PSO

“We will now be able to analyze similar issues but through different lenses and better identify the breaks in the process that may only be apparent to one stakeholder,” says Karen P. Zimmer, MD, MPH, medical director at the ECRI Institute PSO. “For example, a system may work well in stage and even when implemented, but if a provider creates a work-around, there may be unintended consequences. We are hoping to enhance the learnings and then together come up with solutions that would address these issues,” adds Zimmer.

To view the current advisory panel members, go here.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.